期刊文献+

卵巢恶性淋巴瘤的临床病理特点(附7例分析)

下载PDF
导出
摘要 目的:总结卵巢恶性淋巴瘤的临床病理特点。方法收集并分析2005~2013年收治的7例卵巢恶性非霍奇金淋巴瘤患者的临床资料、组织病理学资料和免疫表型情况。结果7例主要表现为腹痛和腹部包块。病理检查见卵巢结构被破坏,肿瘤细胞弥漫浸润,瘤细胞体积大,形态相对单一,胞质中等量到丰富,胞核圆形或卵圆形,核膜厚,染色质粗,核分裂易见。其中6例诊断为弥漫大B细胞型淋巴瘤,1例诊断为B细胞来源淋巴瘤,因取材组织较少,无法具体分型。免疫组化检查示肿瘤细胞CD20、CD79a阳性,Ki67指数有不同程度的增高。患者预后不良,多在1年内死亡。结论卵巢恶性淋巴瘤罕见,病理类型多为弥漫性大B细胞淋巴瘤,肿瘤细胞弥漫浸润,细胞体积大,形态相对单一,核分裂易见,肿瘤细胞表达B细胞标记CD20、CD79a。该病预后不良。
出处 《山东医药》 CAS 北大核心 2015年第27期40-41,共2页 Shandong Medical Journal
  • 相关文献

参考文献16

  • 1Chorlton I,Norris HJ,King FM.Malignant reticuloendothelial disease involving the ovary as a primary manifestation:a series of 19 lymphomas and 1 granulocytic sarcoma[J].Cancer,1974,34(2):397-407.
  • 2Shacham-Abulafia A,Nagar R,Eitan R,et al.Burkitt's lymphoma of the ovary:case report and review of the literature[J].Acta Haematol,2013,129(3):169-174.
  • 3Hu R,Miao M,Zhang R,et al.Ovary involvement of diffuse large B-cell lymphoma[J].Am J Case Rep,2012,(13):96-98.
  • 4Prollius A,Cronje HS.Lymphoma of the ovary with acute torsion[J].J Obstet Gynaecol,2004,24(7):832-833.
  • 5Islimye-Taskin M,Gokgozoglu L,Kandemir B.Primary ovarian large B-cell lymphoma[J].Case Rep Obstet Gynecol,2013,(493836):1-3.
  • 6Senol T,Doger E,Kahramanoglu I,et al.Five cases of nonhodgkin B-cell lymphoma of the ovary[J].Case Rep Obstet Gynecol,2014,(392758):1-5.
  • 7Yadav R,Sharma MC,Karak AK,et al.Natural history of primary precursor B lymphoblastic lymphoma of the ovary:Report of a rare case[J].J Obstet Gynaecol Res,2013,39(2):611-616.
  • 8颜笑健,梁立治,熊樱.8例卵巢非霍奇金淋巴瘤临床分析[J].肿瘤学杂志,2001,7(4):236-238. 被引量:5
  • 9Anwer S,Murdoch J,Pawade J,et al.Is the ovary a sanctuary for non-Hodgkin's lymphoma?Successful surgical management[J].Br J Hosp Med(Lond),2009,70(9):538-539.
  • 10Hu R,Miao M,Zhang R,et al.Ovary involvement of diffuse large B-cell lympoma[J].Am J Case Rep,2012,(13):96-98.

二级参考文献28

  • 1王文福,孙蕊,赵霞玉,李玉芝.卵巢及子宫颈恶性淋巴瘤10例临床分析[J].中华妇产科杂志,1994,29(1):23-26. 被引量:25
  • 2章文华 王奇璐.女性生殖器官原发恶性淋巴瘤.恶性淋巴瘤的诊断与治疗[M].北京:北京医科大学中国协和医科大学联合出版社,1997.355-358.
  • 3钱宏 曹泽毅 等.卵巢恶性淋巴瘤.妇科肿瘤学[M].北京:北京出版社,1998.999-1000.
  • 4Miyashita T,Reed JC.Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line[J].Blood,1993,81 (1):151-157.
  • 5Tai SK,Lee JI,Ang K K,et al.Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication[J].Clin Cancer Res,2004,10(16):5554-5557.
  • 6An H J,Kim KR,Kim IS,et al.Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma:a population-based study[J].Mod Pathol,2005,18 (4):528 -534.
  • 7Hermine O,Haioun C,Lepage E,et al.Prognostic significance of bcl-2 protein in expression in aggressive non-Hodgkin′s lymphoma:Groupe d′Etude des Lymphomas de I′Adulte (GELA)[J].Blood,1996,87(1):265-272.
  • 8Gascoyne RD,Adomat SA,Krajewski S,et al.Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin′s lymphoma[J].Blood,1997,90(1):244-251.
  • 9Iyengar P, Ismiil N, Deodhare S. Precursor B-cell lymphoblastic lymphoma of the ovaries: an immunohistochemical study and review of the literature [J]. Int J Gynecol Pathol, 2004, 23(2):193- 197.
  • 10周小鸽,陈辉树主译.WHO造血与淋巴组织肿瘤病理学和遗传学分类[M].北京:人民卫生出版社,2006.2-3.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部